Healthcare >> CEO Interviews >> October 26, 2004

Nancy Chang – Tanox Inc (tnox)

NANCY T. CHANG is President and Chief Executive Officer of Tanox, Inc. Dr. Chang draws on 22 years of biotechnology experience to guide the company's strategic vision. Previously, Dr. Chang served as Chairman of the Board of Directors since she co-founded the company in 1986 to March 2004. She has been CEO since June 1990. Tanox was created to address significant unmet medical needs in the areas of asthma, allergy, inflammation and diseases affecting the human immune system. Before launching Tanox, Dr. Chang served as Associate Professor at Baylor College of Medicine in the division of Molecular Virology and as Director of Research, Molecular Biology Group, for Centocor, Inc., a biopharmaceutical company. Dr. Chang has received numerous academic, national and international awards for her business acumen and contributions to the biopharmaceutical industry. She was inducted into the Texas Science Hall of Fame in 2001 for exemplary achievement in science and is the recipient of several awards, such as the Association of Women in Computing: Top 20 Houston Women in Technology and Houston Entrepreneur of Year. As an active member in the biopharmaceutical industry, Dr. Chang has published more than 35 papers on topics ranging from monoclonal antibodies to HIV and holds seven patents. She is a current Board member of the Houston Technology Center, BioHouston and the Greater Houston Partnership. She received her Doctorate in Biological Chemistry from Harvard University. Profile
TWST: What has gone on at Tanox over the past year that investors should

focus on?

Dr. Chang: This has been a very exciting year for Tanox, and we can look

at the last 12 months for the